Home › Funds › Occam Crest Management LP › TGTX
Occam Crest Management LP position in TGTX
TG THERAPEUTICS INC · Health Care
Occam Crest Management LP reported holding 377,229 shares of TGTX (TG THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$21.0M, representing 11.87% of its reported portfolio and ranking #2 among its reported holdings. Occam Crest Management LP has disclosed TGTX holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Occam Crest Management LP's TGTX position evolved
Occam Crest Management LP first disclosed a stake in TGTX in Q3 2025 at 409,595 shares (US$14.8M). The position peaked in Q2 2026 at 425,000 shares, worth US$22.7M. Across 5 filings, Occam Crest Management LP increased the stake 1 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 377,229 shares valued at US$21.0M — a reduction of -47,771 shares quarter over quarter.. Notable position changes include a 44% increase in Q1 2026 (shares rose 65% over the following quarter), a 26% trim in Q2 2026 (shares rose 2% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 409.60K | $14.80M | New |
| Q4 2025 | 401.60K | $11.97M | Reduce |
| Q1 2026 | 577.00K | $19.17M | Add |
| Q2 2026 | 425.00K | $22.73M | Reduce |
| Q3 2026 | 377.23K | $21.04M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TGTX and 13F data
TGTX (TG THERAPEUTICS INC) is a Health Care company. 47 other funds we track also report a position in TGTX — the largest reported positions include Soleus Capital Management, L.P. (US$160.9M), CONGRESS ASSET MANAGEMENT CO (US$145.4M), Opaleye Management Inc. (US$29.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TGTX
- Soleus Capital Management, L.P. 2.93M sh · $160.86M · Q2 2026
- CONGRESS ASSET MANAGEMENT CO 2.61M sh · $145.39M · Q3 2026
- Opaleye Management Inc. 535.00K sh · $29.39M · Q2 2026
- Penn Capital Management Company, LLC 480.88K sh · $26.88M · Q3 2026
- 683 Capital Management, LLC 389.08K sh · $21.38M · Q2 2026
More on Occam Crest Management LP
FAQ
How long has Occam Crest Management LP held TGTX?
Occam Crest Management LP has disclosed TGTX holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
What is Occam Crest Management LP's current position in TGTX?
As of Q3 2026, Occam Crest Management LP holds 377.23K shares of TGTX (TG THERAPEUTICS INC), valued at $21.04M, representing 11.87% of its reported portfolio and ranking #2.
Has Occam Crest Management LP been buying or selling TGTX?
In the latest 13F filing (Q3 2026), Occam Crest Management LP reduced its position in TGTX. The position peaked in Q2 2026 at 425.00K shares.
Which other funds hold TGTX?
Other major institutional holders of TGTX include Soleus Capital Management, L.P., CONGRESS ASSET MANAGEMENT CO, Opaleye Management Inc., among 47 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.